About Meiji Seika Pharma
Meiji Seika Pharma is a company based in Chuo (Japan) founded in 1916. It operates as a B2B. Meiji Seika Pharma has completed 1 acquisition, including Medreich. Meiji Seika Pharma operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Chuo, Japan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Meiji Seika Pharma
Detailed funding history for Meiji Seika Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Meiji Seika Pharma
Meiji Seika Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medreich.
Investment portfolio details for Meiji Seika Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical contract manufacturing and development services are provided.
|
Locked | Locked | 1984 | Locked |
Complete acquisition details for Meiji Seika Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Meiji Seika Pharma
Detailed financials for Meiji Seika Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Meiji Seika Pharma Comparisons
Peer comparison for Meiji Seika Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Meiji Seika Pharma
Meiji Seika Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Meiji Seika Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Meiji Seika Pharma
Complete news archive for Meiji Seika Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meiji Seika Pharma
Meiji Seika Pharma was founded in 1916.
Meiji Seika Pharma is headquartered in Chuo, Japan. It is registered at Chuo, Tokyo, Japan.
Meiji Seika Pharma specializes in developing, manufacturing, and marketing human vaccines, antibiotics, and prescription drugs, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and vaccines and antibiotics. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Meiji Seika Pharma's top competitors include Merck, Roivant Sciences and AbbVie.
Meiji Seika Pharma has made 1 acquisition, including Medreich.